MedPath

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick

Not Applicable
Conditions
Diabetes
Registration Number
NCT02045758
Lead Sponsor
Seventh Sense Biosystems
Brief Summary

This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Healthy Subject Group

    1. Male and female volunteers 18 years of age or older.
    2. Voluntary written consent to participate in this study. Diabetic Subject Group
    <!-- -->
    1. Male and female volunteers 18 years of age or older.
    2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report.
    3. Voluntary written consent to participate in this study.
Exclusion Criteria
  1. Subjects who are pregnant or nursing mothers by self-report.
  2. Subjects with a history of skin disorders or who present with abnormal skin integrity or atypical skin health within the areas to be tested.
  3. Subjects with a missing index or middle finger on either hand or a missing forearm
  4. Subjects who have known allergies to titanium.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Non-Inferiority of Analyte LevelsDay 1

The study will compare the concentrations of various analytes in blood samples collected by both collection methods in a single 2 hour session.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seventh Sense Biosystems

🇺🇸

Cambridge, Massachusetts, United States

Seventh Sense Biosystems
🇺🇸Cambridge, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.